Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis.
Masayuki NishideKei NishimuraHiroaki MatsushitaRyuya EdahiroSachi InukaiHiroshi ShimagamiShoji KawadaYasuhiro KatoTakahiro KawasakiKohei TsujimotoHokuto KamonRyusuke OmiyaYukinori OkadaKunihiro HattoriMasashi NarazakiAtsushi KumanogohPublished in: Nature communications (2023)
The immunological basis of the clinical heterogeneity in autoimmune vasculitis remains poorly understood. In this study, we conduct single-cell transcriptome analyses on peripheral blood mononuclear cells (PBMCs) from newly-onset patients with microscopic polyangiitis (MPA). Increased proportions of activated CD14 + monocytes and CD14 + monocytes expressing interferon signature genes (ISGs) are distinctive features of MPA. Patient-specific analysis further classifies MPA into two groups. The MPA-MONO group is characterized by a high proportion of activated CD14 + monocytes, which persist before and after immunosuppressive therapy. These patients are clinically defined by increased monocyte ratio in the total PBMC count and have a high relapse rate. The MPA-IFN group is characterized by a high proportion of ISG + CD14 + monocytes. These patients are clinically defined by high serum interferon-alpha concentrations and show good response to immunosuppressive therapy. Our findings identify the immunological phenotypes of MPA and provide clinical insights for personalized treatment and accurate prognostic prediction.
Keyphrases
- single cell
- dendritic cells
- end stage renal disease
- rna seq
- newly diagnosed
- chronic kidney disease
- ejection fraction
- genome wide
- peritoneal dialysis
- immune response
- gene expression
- high throughput
- prognostic factors
- stem cells
- multiple sclerosis
- patient reported outcomes
- mesenchymal stem cells
- endothelial cells
- replacement therapy
- smoking cessation